Fagron Recalls Succinylcholine Chloride Syringes Due to Sterility Concerns
Fagron Compounding Services is voluntarily recalling 1,056 syringes of Succinylcholine Chloride because the company cannot ensure the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury risks or hospitalization reports, even though specific injury counts are not provided in the source text.
Plain-English summary
Fagron Compounding Services LLC dba Fagron Sterile Services has initiated a voluntary recall of 1,056 syringes of Succinylcholine Chloride, 100 mg per 5mL (20 mg per mL). The product is labeled for IV use only and was distributed nationwide in the USA.
The recall was initiated due to a lack of assurance of sterility. The affected lots are C274-000000331 (Best Use Date 08/30/2017), C274-000001274 (Best Use Date 09/07/2017), and C274-000001326 (Best Use Date 09/14/2017).
Healthcare providers and patients should stop using the recalled product and contact the recalling firm for further instructions.
The recalled product
- Product
- Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405
- Category
- Drug — Sterile Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: C274-000000331
- BUD 08/30/2017
- C274-000001274
- BUD 09/07/2017
- C274-000001326
- BUD 09/14/2017
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Fagron Compounding Services LLC dba Fagron Sterile Services
See all →- SevereFagron Recalls Neostigmine Methylsulfate Syringes Due to Labeling Error
FDA (Drugs) · 2018-07-11
- SevereFagron Recalls Neostigmine Methylsulfate Syringes Due to Labeling Error
FDA (Drugs) · 2018-07-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22